{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T09:08:41Z","timestamp":1764493721330},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.pep.2012.08.015","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T20:22:01Z","timestamp":1347394921000},"page":"75-81","source":"Crossref","is-referenced-by-count":10,"title":["Expression, purification and characterization of a human single-chain Fv antibody fragment fused with the Fc of an IgG1 targeting a rabies antigen in Pichia pastoris"],"prefix":"10.1016","volume":"86","author":[{"given":"Ding-ding","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-man","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-qun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2012.08.015_b0005","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","article-title":"Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans recent advances in prevention and control of rabies","volume":"3","author":"M\u00fcller","year":"2009","journal-title":"PLoS Neglect. Trop. Dis."},{"key":"10.1016\/j.pep.2012.08.015_b0010","unstructured":"WHO, Rabies, Fact Sheet 99, 2001, pp. 1\u20133."},{"key":"10.1016\/j.pep.2012.08.015_b0015","series-title":"Consultation on a Monoclonal Antibody Cocktail for Rabies Post Exposure Treatment","author":"WHO","year":"2002"},{"key":"10.1016\/j.pep.2012.08.015_b0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-1759(99)00223-9","article-title":"The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure","volume":"235","author":"Champion","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.pep.2012.08.015_b0025","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1348-0421.2010.00262.x","article-title":"Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus","volume":"54","author":"Takashi","year":"2010","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.pep.2012.08.015_b0030","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","article-title":"First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity","volume":"26","author":"Bakker","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.pep.2012.08.015_b0035","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2460\/ajvr.2002.63.1096","article-title":"Postexposure prophylaxis for prevention of rabies in dogs","volume":"63","author":"Hanlon","year":"2002","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.pep.2012.08.015_b0040","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.molimm.2012.03.015","article-title":"A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency","volume":"51","author":"Ye","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.pep.2012.08.015_b0045","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/aps.2010.209","article-title":"Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus","volume":"32","author":"Chen","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.pep.2012.08.015_b0050","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1093\/jaoac\/93.1.80","article-title":"An Expression system for the E. coli fermentation of recombinant antibody Fab fragments from mice and rabbits","volume":"93","author":"Wiebe","year":"2010","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.pep.2012.08.015_b0055","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1742-4658.2009.07499.x","article-title":"Application of the Fc fusion format to generate tag-free bi-specific diabodies","volume":"277","author":"Asano","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.pep.2012.08.015_b0060","unstructured":"W.Q. Yan, D.D. Wang, Recombinant antibody against rabies antigen[P], China, The number of the patent: ZL 2007 1 0055307.1."},{"key":"10.1016\/j.pep.2012.08.015_b0065","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"Casadeval","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.pep.2012.08.015_b0070","unstructured":"Human rabies prevention \u2013 United States, 2008: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR 57 (2008) 1\u201326, 28."},{"key":"10.1016\/j.pep.2012.08.015_b0075","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2460\/ajvr.2002.63.1096","article-title":"Postexposure prophylaxis for prevention of rabies in dogs","volume":"63","author":"Hanlon","year":"2002","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.pep.2012.08.015_b0080","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.antiviral.2011.06.002","article-title":"G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates","volume":"91","author":"Wang","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.pep.2012.08.015_b0085","first-page":"11","article-title":"Generation of human monoclonal antibody Fab fragment to rabies virus by phage display technology","volume":"17","author":"Zhang","year":"2001","journal-title":"Chin. J. Virol."},{"key":"10.1016\/j.pep.2012.08.015_b0090","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/bit.22756","article-title":"Antibody expression kinetics in glycoengineered Pichia pastoris","volume":"106","author":"Potgieter","year":"2010","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.pep.2012.08.015_b0095","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nbt1178","article-title":"Optimization of humanized IgGs in glycoengineered Pichia pastoris","volume":"24","author":"Li","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pep.2012.08.015_b0100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00403-008-0908-4","article-title":"Secretory expression of human ScFv against keratin in Pichia pastoris and its effects on cultured keratinocytes","volume":"301","author":"Fan","year":"2009","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.pep.2012.08.015_b0105","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nbt0994-890","article-title":"Mammalian cell expression of single-chain Fv (scFv) antibody proteins and their C-terminal fusions with interleukin-2 and other effector domains","volume":"12","author":"Dorai","year":"1994","journal-title":"Biotechnology"},{"key":"10.1016\/j.pep.2012.08.015_b0110","doi-asserted-by":"crossref","first-page":"14336","DOI":"10.1073\/pnas.0805942105","article-title":"Isolation of human monoclonal antibodies by mammalian cell display","volume":"105","author":"Beerli","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.pep.2012.08.015_b0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1470-8744.1999.tb00901.x","article-title":"Towards molecular farming in the future: Pichia pastoris-based production of single-chain antibody fragments","volume":"30","author":"Rainer","year":"1999","journal-title":"Biotechnol. Appl. Biochem."}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592812002331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592812002331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T03:42:55Z","timestamp":1714362175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592812002331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1046592812002331"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2012.08.015","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}